MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 150 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q2 2015. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $133,005,000 | -40.3% | 107,262 | +48.4% | 0.00% | – |
Q1 2017 | $222,620,000 | +129330.2% | 72,279 | +71.7% | 0.00% | – |
Q4 2016 | $172,000 | -63.9% | 42,097 | -43.9% | 0.00% | -100.0% |
Q3 2016 | $477,000 | -73.9% | 75,097 | -77.9% | 0.00% | -50.0% |
Q2 2016 | $1,828,000 | -83.3% | 339,097 | -74.1% | 0.00% | -84.6% |
Q1 2016 | $10,954,000 | +9.6% | 1,308,762 | +3.5% | 0.01% | +18.2% |
Q4 2015 | $9,992,000 | -10.2% | 1,264,799 | -3.2% | 0.01% | -8.3% |
Q3 2015 | $11,122,000 | +2.4% | 1,306,844 | +48.8% | 0.01% | +20.0% |
Q2 2015 | $10,859,000 | +5.0% | 878,144 | +0.9% | 0.01% | 0.0% |
Q1 2015 | $10,338,000 | +6.7% | 870,244 | +1.5% | 0.01% | +11.1% |
Q4 2014 | $9,686,000 | +31.4% | 857,197 | +2.1% | 0.01% | +28.6% |
Q3 2014 | $7,370,000 | +25.6% | 839,397 | +4.3% | 0.01% | +16.7% |
Q2 2014 | $5,868,000 | +44.6% | 804,997 | 0.0% | 0.01% | +50.0% |
Q1 2014 | $4,057,000 | -3.9% | 804,997 | +1.8% | 0.00% | -20.0% |
Q4 2013 | $4,221,000 | +41.6% | 790,497 | +0.8% | 0.01% | +25.0% |
Q3 2013 | $2,981,000 | +1131.8% | 784,597 | +2085.7% | 0.00% | – |
Q2 2013 | $242,000 | – | 35,897 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lagoda Investment Management, L.P. | 775,571 | $2,389,000 | 0.93% |
KEMPNER CAPITAL MANAGEMENT INC. | 148,985 | $459,000 | 0.31% |
Yakira Capital Management, Inc. | 248,420 | $765,000 | 0.27% |
GARRISON BRADFORD & ASSOCIATES INC | 87,700 | $270,000 | 0.24% |
Cannell & Co. | 1,212,478 | $3,734,000 | 0.13% |
LeJeune Puetz Investment Counsel LLC | 3,976 | $180,000 | 0.13% |
ALPINE WOODS CAPITAL INVESTORS, LLC | 726,000 | $2,236,000 | 0.12% |
Virtus ETF Advisers LLC | 198,735 | $612,000 | 0.11% |
STONERIDGE INVESTMENT PARTNERS LLC | 199,227 | $614,000 | 0.08% |
Birchview Capital, LP | 44,000 | $136,000 | 0.08% |